These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 29252651

  • 21. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
    Kato I, Furuya M, Matsuo K, Kawabata Y, Tanaka R, Ohashi K.
    Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281
    [Abstract] [Full Text] [Related]

  • 22. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis.
    Reddy K, Ramirez L, Kukreja K, Venkatramani R.
    J Pediatr Hematol Oncol; 2021 Mar 01; 43(2):e215-e218. PubMed ID: 31714440
    [Abstract] [Full Text] [Related]

  • 23. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.
    Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T.
    Ann Oncol; 2015 Oct 01; 26(10):2149-54. PubMed ID: 26205395
    [Abstract] [Full Text] [Related]

  • 24. Histopathological response to denosumab in giant cell tumours of bone - A review of 11 cases.
    Kumar R, Mallya V, Mandal S, Tomar R, Khurana N, Maini L.
    J Cancer Res Ther; 2023 Oct 01; 19(3):768-772. PubMed ID: 37470608
    [Abstract] [Full Text] [Related]

  • 25. Current concepts in the treatment of giant cell tumour of bone.
    van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H.
    Curr Opin Oncol; 2020 Jul 01; 32(4):332-338. PubMed ID: 32541321
    [Abstract] [Full Text] [Related]

  • 26. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images.
    Yi J, Lee YH, Kim SK, Kim SH, Song HT, Shin KH, Suh JS.
    J Orthop Sci; 2018 May 01; 23(3):570-577. PubMed ID: 29429890
    [Abstract] [Full Text] [Related]

  • 27. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
    Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH.
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation.
    Kerr DA, Brcic I, Diaz-Perez JA, Shih A, Wilky BA, Pretell-Mazzini J, Subhawong TK, Nielsen GP, Rosenberg AE.
    Am J Surg Pathol; 2021 Jan 08; 45(1):93-100. PubMed ID: 32773532
    [Abstract] [Full Text] [Related]

  • 32. In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid.
    Shibuya I, Takami M, Miyamoto A, Karakawa A, Dezawa A, Nakamura S, Kamijo R.
    Pathol Oncol Res; 2019 Jan 08; 25(1):409-419. PubMed ID: 29159783
    [Abstract] [Full Text] [Related]

  • 33. Preoperative Denosumab plus Surgery in the Management of Giant Cell Tumor of Bone: A Comprehensive Narrative Literature Review.
    Abu-Zaid A, Alaqaili SI, Ahmad SO, Bin Hazzaa I, Alharbi H.
    Gulf J Oncolog; 2019 May 08; 1(30):67-75. PubMed ID: 31242985
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I.
    Clin Cancer Res; 2012 Aug 15; 18(16):4415-24. PubMed ID: 22711702
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A thoracic spinal bone giant cell tumor in a skeletally immature girl. A case report and literature review.
    Sigwalt L, Bourgeois E, Eid A, Durand C, Griffet J, Courvoisier A.
    Childs Nerv Syst; 2016 May 15; 32(5):873-6. PubMed ID: 26732064
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
    Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC.
    Orthop Surg; 2019 Dec 15; 11(6):1101-1108. PubMed ID: 31762217
    [Abstract] [Full Text] [Related]

  • 40. A case of pelvic giant cell tumor of bone, complete remission with denosumab: long duration of response.
    Bilgetekin I, Mammadkhanli O, Basal FB, Kandemir O, Canbay S, Oksuzoglu B.
    Anticancer Drugs; 2020 Jun 15; 31(5):533-535. PubMed ID: 31743134
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.